[
    {
        "question": "How many patients have Grade 0 gliomas in the dataset? Express the answer as an integer.",
        "ground_truth": "487",
        "derivation": "_.countBy(data, 'Grade')",
        "type": "Information Retrieval",
        "subtype": "Direct Value Retrieval",
        "difficulty": "easy",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "487",
        "score": 1
    },
    {
        "question": "What is the count of patients with concurrent IDH1 and TP53 mutations (both values = 1)? Express the answer as an integer.",
        "ground_truth": "238",
        "derivation": "data.filter(row => row.IDH1 === 1 && row.TP53 === 1).length",
        "type": "Information Retrieval",
        "subtype": "Conditional Retrieval and Filtering",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "238",
        "score": 1
    },
    {
        "question": "Which mutation appears most frequently in the dataset? Report the mutation name and count in the format: 'MUTATION_NAME: COUNT'.",
        "ground_truth": "IDH1: 404",
        "derivation": "Object.entries(mutationCounts).sort((a,b) => b[1] - a[1])[0]",
        "type": "Information Retrieval",
        "subtype": "Comparison and Ranking",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "IDH1: 404",
        "score": 1
    },
    {
        "question": "Calculate the mean age at diagnosis for each glioma grade. Round to 2 decimal places and express as 'Grade X: YY.ZZ'.",
        "ground_truth": "Grade 0: 43.87, Grade 1: 60.70",
        "derivation": "_.groupBy(data, 'Grade').map(group => calculateMean(group.map(p => p.Age_at_diagnosis)))",
        "type": "Statistics",
        "subtype": "Descriptive Statistics",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "Grade 0: 43.87 Grade 1: 60.70",
        "score": 1
    },
    {
        "question": "What percentage of Grade 1 glioma patients have EGFR mutations? Round to 1 decimal place and include the raw counts in parentheses.",
        "ground_truth": "31.8% (112/352)",
        "derivation": "data.filter(row => row.Grade === 4 && row.EGFR === 1).length / data.filter(row => row.Grade === 4).length",
        "type": "Statistics",
        "subtype": "Descriptive Statistics",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "23.0% (81/352)",
        "score": 0
    },
    {
        "question": "Calculate the mean and standard deviation of Age_at_diagnosis. Round to 2 decimal places and express as 'Mean: XX.XX, SD: YY.YY'.",
        "ground_truth": "Mean: 50.94, SD: 15.69",
        "derivation": "const ages = data.map(row => row.Age_at_diagnosis).filter(age => age != null); calculateMean(ages); standardDeviation(ages)",
        "type": "Statistics",
        "subtype": "Descriptive Statistics",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "Mean: 50.94, SD: 15.70",
        "score": 1
    },
    {
        "question": "How many patients have both IDH1 and IDH2 mutations (both values = 1)? Express the answer as an integer.",
        "ground_truth": "0",
        "derivation": "data.filter(row => row.IDH1 === 1 && row.IDH2 === 1).length",
        "type": "Information Retrieval",
        "subtype": "Pattern and Trend Recognition",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "0",
        "score": 1
    },
    {
        "question": "Calculate the EGFR mutation rate for each glioma grade. Round to 2 decimal places and express as percentages in the format 'Grade X: YY.ZZ%'.",
        "ground_truth": "Grade 0: 6.37%, Grade 1: 23.01%",
        "derivation": "const egfrByGrade = _.groupBy(data, 'Grade'); Object.entries(egfrByGrade).map(([grade, patients]) => ({grade, egfrRate: patients.filter(p => p.EGFR === 1).length / patients.length}))",
        "type": "Statistics",
        "subtype": "Descriptive Statistics",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "Grade 0: 6.37%; Grade 1: 23.01%",
        "score": 1
    },
    {
        "question": "Provide a population summary in the format: 'Total: N; Grade distribution: X/Y; Gender by grade: M0/F0, M1/F1; Most common mutation: NAME (COUNT)'.",
        "ground_truth": "Total: 839; Grade distribution: 487/352; Gender by grade: 271/216, 217/135; Most common mutation: IDH1 (404)",
        "derivation": "Multiple analyses combined",
        "type": "Information Retrieval",
        "subtype": "Summary and Reporting",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "Total: 839; Grade distribution: 487/352; Gender by grade: 271/216, 217/135; Most common mutation: IDH1 (404)",
        "score": 1
    },
    {
        "question": "Calculate the mean age and 95% CI for patients with IDH1 mutations. Round to 2 decimal places and express as 'Mean: XX.XX, CI: [YY.YY, ZZ.ZZ]'.",
        "ground_truth": "Mean: 41.67, CI: [40.48, 42.87]",
        "derivation": "confidenceInterval(data.filter(row => row.IDH1 === 1).map(row => row.Age_at_diagnosis))",
        "type": "Statistics",
        "subtype": "Confidence Intervals",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "Mean: 41.67, CI: [40.47, 42.87]",
        "score": 1
    },
    {
        "question": "Calculate the frequency of IDH1, TP53, and ATRX mutations for age groups: <30, 30-45, 45-60, and >60. Express as percentages rounded to 1 decimal place in the format 'Age GROUP: IDH1 (XX.X%), TP53 (YY.Y%), ATRX (ZZ.Z%)'.",
        "ground_truth": "Age <30: IDH1 (82.9%), TP53 (72.4%), ATRX (63.2%); Age 30-45: IDH1 (83.3%), TP53 (59.8%), ATRX (44.3%); Age 45-60: IDH1 (38.0%), TP53 (30.2%), ATRX (15.3%); Age >60: IDH1 (14.9%), TP53 (26.3%), ATRX (8.0%)",
        "derivation": "Mutation frequencies calculated by age group using groupBy and frequency counts",
        "type": "Statistics",
        "subtype": "Descriptive Statistics",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "<30: IDH1 (82.9%), TP53 (72.4%), ATRX (63.2%)\n30-45: IDH1 (83.3%), TP53 (59.8%), ATRX (44.3%)\n45-60: IDH1 (38.0%), TP53 (30.2%), ATRX (15.3%)\n>60: IDH1 (14.9%), TP53 (26.3%), ATRX (8.0%)",
        "score": 1
    },
    {
        "question": "Compare the mean age at diagnosis between IDH1 mutated and wild-type patients. Express as 'IDH1-mutated: XX.XX years, IDH1-wildtype: YY.YY years', rounded to 2 decimal places.",
        "ground_truth": "IDH1-mutated: 41.67 years, IDH1-wildtype: 60.00 years",
        "derivation": "Analysis of age distributions and confidence intervals by mutation status",
        "type": "Information Retrieval",
        "subtype": "Contextual Interpretation and Explanation",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "IDH1-mutated: 41.67 years, IDH1-wildtype: 59.54 years",
        "score": 0
    },
    {
        "question": "Calculate mutation frequencies by gender. Express as percentages rounded to 1 decimal place in format 'Gender X: IDH1 (XX.X%), TP53 (YY.Y%), ATRX (ZZ.Z%)'.",
        "ground_truth": "Gender 0: IDH1 (46.1%), TP53 (41.4%), ATRX (23.8%); Gender 1: IDH1 (51.0%), TP53 (41.6%), ATRX (28.8%)",
        "derivation": "Analyzed gender-specific mutation rates using data grouping and frequency calculations",
        "type": "Statistics",
        "subtype": "Descriptive Statistics",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "Gender 0: IDH1 (46.1%), TP53 (41.4%), ATRX (23.8%); Gender 1: IDH1 (51.0%), TP53 (41.6%), ATRX (28.8%)",
        "score": 1
    },
    {
        "question": "Group patients into risk profiles based on mutation combinations. Report counts and mean ages in format 'RISK_LEVEL (COUNT patients, mean age XX.XX)'.",
        "ground_truth": "Low risk (404 patients, mean age 41.64), High risk (203 patients, mean age 60.89), Mixed (12 patients, mean age 41.39), No risk mutations (220 patients, mean age 59.35)",
        "derivation": "Created risk profiles based on combinations of high-risk (EGFR, PTEN) and low-risk (IDH1, CIC) mutations",
        "type": "Statistics",
        "subtype": "Descriptive Statistics",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "The risk profiles, counts, and mean ages are as follows:\n\nRISK_LEVEL_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0 (67 patients, mean age 59.07)\nRISK_LEVEL_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_1 (6 patients, mean age 69.00)\nRISK_LEVEL_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_0_1_0 (4 patients, mean age 66.86)\n... (and so on for all the other risk levels printed in the observation)",
        "score": 0
    },
    {
        "question": "Calculate mutation frequencies by race. Express as 'Race X (n=N): IDH1 XX.X%, TP53 YY.Y%, ATRX ZZ.Z%'.",
        "ground_truth": "Race 0 (n=765): IDH1 49.8%, TP53 42.7%, ATRX 26.3%; Race 1 (n=59): IDH1 25.4%, TP53 30.5%, ATRX 22.0%; Race 2 (n=14): IDH1 57.1%, TP53 21.4%, ATRX 21.4%",
        "derivation": "Calculated mutation rates by racial groups using groupBy and frequency analysis",
        "type": "Information Retrieval",
        "subtype": "Multi-Column Analysis and Summarization",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "Race 0 (n=765): IDH1 49.8%, TP53 42.7%, ATRX 26.3%\nRace 1 (n=59): IDH1 25.4%, TP53 30.5%, ATRX 22.0%\nRace 2 (n=14): IDH1 57.1%, TP53 21.4%, ATRX 21.4%\nRace 3 (n=1): IDH1 0.0%, TP53 0.0%, ATRX 0.0%",
        "score": 1
    },
    {
        "question": "Count patients by total number of mutations. Express as 'X mutations: N patients' for each group.",
        "ground_truth": "0 mutations: 124 patients, 1 mutation: 213 patients, 2 mutations: 262 patients, 3 mutations: 201 patients, 4 mutations: 35 patients, 5-7 mutations: 4 patients",
        "derivation": "Counted total number of mutations per patient and created frequency distribution",
        "type": "Statistics",
        "subtype": "Frequency and Distribution Analysis",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "0 mutations: 67 patients\n1 mutations: 176 patients\n2 mutations: 224 patients\n3 mutations: 252 patients\n4 mutations: 93 patients\n5 mutations: 20 patients\n6 mutations: 3 patients\n9 mutations: 1 patients\n13 mutations: 1 patients\n17 mutations: 2 patients",
        "score": 0
    },
    {
        "question": "Calculate IDH1 mutation frequency by glioma grade. Express as 'Grade X: N/M (XX.X%)'.",
        "ground_truth": "Grade 0: 381/487 (78.2%), Grade 1: 23/352 (6.5%)",
        "derivation": "_.groupBy(data, 'Grade'); _.mapValues(groups, g => _.countBy(g, 'IDH1'))",
        "type": "Statistics",
        "subtype": "Frequency and Distribution Analysis",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "Grade 0: 381/487 (78.2%)\nGrade 1: 23/352 (6.5%)",
        "score": 1
    },
    {
        "question": "Calculate mean age for IDH1-mutant vs wildtype patients. Express as 'IDH1-mutant: XX.X years, IDH1-wildtype: YY.Y years'.",
        "ground_truth": "IDH1-mutant: 41.7 years, IDH1-wildtype: 59.5 years",
        "derivation": "_.groupBy(data, 'IDH1'); calculate mean age for each group",
        "type": "Statistics",
        "subtype": "Descriptive Statistics",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "IDH1-mutant: 41.7 years, IDH1-wildtype: 59.5 years",
        "score": 1
    },
    {
        "question": "Calculate TP53 mutation rates in IDH1-mutant vs wildtype cases. Express as 'IDH1-mutant: N/M (XX.X%), IDH1-wildtype: P/Q (YY.Y%)'.",
        "ground_truth": "IDH1-mutant: 238/404 (58.9%), IDH1-wildtype: 110/435 (25.3%)",
        "derivation": "_.countBy(data, row => `IDH1:${row.IDH1},TP53:${row.TP53}`)",
        "type": "Information Retrieval",
        "subtype": "Pattern and Trend Recognition",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "IDH1-mutant: 238/404 (58.9%), IDH1-wildtype: 110/435 (25.3%)",
        "score": 1
    },
    {
        "question": "Count total patients by gender. Express as 'N females (XX.X%), M males (YY.Y%)', percentages rounded to 1 decimal place.",
        "ground_truth": "488 females (58.2%), 351 males (41.8%)",
        "derivation": "_.countBy(data, 'Gender')",
        "type": "Information Retrieval",
        "subtype": "Multi-Column Analysis and Summarization",
        "difficulty": "easy",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "488 females (58.2%), 351 males (41.8%)",
        "score": 1
    },
    {
        "question": "Calculate IDH1 mutation frequency in Grade 0 gliomas. Express as 'N/M (XX.X%)'.",
        "ground_truth": "381/487 (78.2%)",
        "derivation": "filterByGrade(data, 0).filter(row => row.IDH1 === 1).length / filterByGrade(data, 0).length",
        "type": "Information Retrieval",
        "subtype": "Conditional Retrieval and Filtering",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "381/487 (78.2%)",
        "score": 1
    },
    {
        "question": "Calculate the co-occurrence rate of EGFR and IDH1 mutations. Express as 'N/M (XX.X%) of EGFR-mutant cases have IDH1 mutations'.",
        "ground_truth": "4/112 (3.6%) of EGFR-mutant cases have IDH1 mutations",
        "derivation": "_.countBy(data, row => `EGFR:${row.EGFR},IDH1:${row.IDH1}`)",
        "type": "Information Retrieval",
        "subtype": "Pattern and Trend Recognition",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "3/112 (2.7% of EGFR-mutant cases have IDH1 mutations)",
        "score": 0
    },
    {
        "question": "Compare mean age between IDH1-mutant and wildtype patients. Express as 'IDH1-mutant: XX.X years, IDH1-wildtype: YY.Y years'.",
        "ground_truth": "IDH1-mutant: 41.7 years, IDH1-wildtype: 59.5 years",
        "derivation": "compare mean age between IDH1-mutant and wildtype groups",
        "type": "Statistics",
        "subtype": "Descriptive Statistics",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "IDH1-mutant: 41.7 years, IDH1-wildtype: 59.5 years",
        "score": 1
    },
    {
        "question": "Calculate the frequency of ATRX mutations in IDH1-mutant cases. Express as 'N/M (XX.X%) of ATRX-mutant cases occur in IDH1-mutant gliomas'.",
        "ground_truth": "189/217 (87.1%) of ATRX-mutant cases occur in IDH1-mutant gliomas",
        "derivation": "_.countBy(data, row => `ATRX:${row.ATRX},IDH1:${row.IDH1}`)",
        "type": "Information Retrieval",
        "subtype": "Pattern and Trend Recognition",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "188/404 (46.5% of ATRX-mutant cases occur in IDH1-mutant gliomas)",
        "score": 0
    },
    {
        "question": "Calculate concurrent mutation rates in PI3K pathway genes (PIK3CA, PIK3R1, PTEN). Express as 'Concurrent PIK3CA/PIK3R1: N cases (XX.X%), No mutations: M cases (YY.Y%)'.",
        "ground_truth": "Concurrent PIK3CA/PIK3R1: 3 cases (0.36%), No mutations: 591 cases (70.4%)",
        "derivation": "_.countBy(data, row => `PIK3CA:${row.PIK3CA},PIK3R1:${row.PIK3R1},PTEN:${row.PTEN}`)",
        "type": "Information Retrieval",
        "subtype": "Pattern and Trend Recognition",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "Concurrent PIK3CA/PIK3R1: 3 cases (0.4%), No mutations: 591 cases (70.4%)",
        "score": 1
    },
    {
        "question": "Calculate the co-occurrence rate of PTEN and PIK3CA mutations. Express as 'N/M (XX.X%) of PTEN-mutant cases have PIK3CA mutations'.",
        "ground_truth": "7/141 (5.0%) of PTEN-mutant cases have PIK3CA mutations",
        "derivation": "_.countBy(data.filter(row => row.PTEN === 1), 'PIK3CA')",
        "type": "Information Retrieval",
        "subtype": "Pattern and Trend Recognition",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "7/141 (5.0% of PTEN-mutant cases have PIK3CA mutations)",
        "score": 1
    },
    {
        "question": "Calculate IDH1 mutation frequency by race. Express as 'Race X: XX.X%' for each group.",
        "ground_truth": "Race 0: 49.8%, Race 1: 25.4%, Race 2: 57.1%",
        "derivation": "_.mapValues(_.groupBy(data, 'Race'), group => _.countBy(group, 'IDH1'))",
        "type": "Information Retrieval",
        "subtype": "Multi-Column Analysis and Summarization",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "Race 0: 49.8%\nRace 1: 25.4%\nRace 2: 57.1%\nRace 3: 0.0%",
        "score": 1
    },
    {
        "question": "Is there a difference in EGFR mutation frequency across racial groups (yes / no). If so, express as 'Race X: XX.X%' for each group.",
        "ground_truth": "Yes.Race 0: 12.8%, Race 1: 22.0%, Race 2: 7.1%",
        "derivation": "_.mapValues(_.groupBy(data, 'Race'), group => _.countBy(group, 'EGFR'))",
        "type": "Information Retrieval",
        "subtype": "Multi-Column Analysis and Summarization",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "yes\nRace 0: 12.8%\nRace 1: 22.0%\nRace 2: 7.1%\nRace 3: 0.0%",
        "score": 1
    },
    {
        "question": "Calculate the co-occurrence rate of EGFR and PDGFRA mutations. Express as 'N/M (XX.X%) EGFR-mutant cases have PDGFRA mutations, P cases (YY.Y%) have neither'.",
        "ground_truth": "5/112 (4.5%) EGFR-mutant cases have PDGFRA mutations, 710 cases (84.6%) have neither",
        "derivation": "_.countBy(data, row => `EGFR:${row.EGFR},PDGFRA:${row.PDGFRA}`)",
        "type": "Information Retrieval",
        "subtype": "Pattern and Trend Recognition",
        "difficulty": "medium",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "5/112 (4.5%) EGFR-mutant cases have PDGFRA mutations, 710 cases (84.6%) have neither",
        "score": 1
    },
    {
        "question": "Calculate PDGFRA mutation associations with EGFR and IDH1 status. Express as 'N/M (XX.X%) in EGFR-wildtype, P/Q (YY.Y%) in IDH1-wildtype'.",
        "ground_truth": "17/22 (77.3%) in EGFR-wildtype, 16/22 (72.7%) in IDH1-wildtype",
        "derivation": "analysis of PDGFRA mutants with EGFR and IDH1 status",
        "type": "Statistics",
        "subtype": "Descriptive Statistics",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "17/727 (2.3%) in EGFR-wildtype, 19/435 (4.4%) in IDH1-wildtype",
        "score": 0
    },
    {
        "question": "Analyze IDH1-ATRX-TP53 triple-positive cases. Express as 'N cases (XX.X%), mean age YY.Y years, Grade 0: ZZ.Z%'.",
        "ground_truth": "171 cases (20.4%), mean age 38.5 years, Grade 0: 90.1%",
        "derivation": "Analysis of co-occurrence patterns and clinical features in triple-positive cases",
        "type": "Information Retrieval",
        "subtype": "Data Aggregation, Grouping and Classification",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "171 cases (20.4%), mean age 38.5 years, Grade 0: 90.1%",
        "score": 1
    },
    {
        "question": "How do alterations in the RTK/PI3K pathway members (EGFR, PDGFRA, PIK3CA, PIK3R1, PTEN) cooperate to drive gliomagenesis? Analyze whether they define specific molecular subtypes by calculating mutation frequencies in the RTK/PI3K pathway.Express as 'They have [similar / different] mechanisms of pathway activation. GENEX [is / is not] mutually exclusive with GENEY, GENEZ [has significant, has limited] co-ocurance with GENEA.",
        "ground_truth": "Yes, they have  different mechanisms for pathway activation. EGFR is mutually exclusive with PDGFRA, PIK3CA/PIK3R1 has limited co-occurrence with PTEN.",
        "derivation": "Complex pathway analysis including mutual exclusivity and co-occurrence patterns",
        "type": "Information Retrieval",
        "subtype": "Pattern and Trend Recognition",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "They have different mechanisms of pathway activation. EGFR is not mutually exclusive with PDGFRA, PIK3CA, PIK3R1, and PTEN, and has significant co-ocurance with all of them. PDGFRA has limited co-ocurance with PIK3CA but significant co-ocurance with PIK3R1 and PTEN. PIK3CA has significant co-ocurance with PIK3R1 and PTEN. PIK3R1 has significant co-ocurance with PTEN. This suggests potential synergistic effects between alterations in these genes, contributing to gliomagenesis.",
        "score": 0
    },
    {
        "question": "Do the distinct molecular profiles in different age groups suggest different cellular origins or evolutionary paths in glioma development (yes / no)? If yes, identify distinct molecular profile and averate age. Express as 'GENEX-GENEY-GENEZ: average age ZZ.Z, GENEA-GENEB: average age WW.W'",
        "ground_truth": "Yes. IDH1-ATRX-TP53: average age 38.5, EGFR-PTEN: average age 60.7",
        "derivation": "Integration of age patterns with molecular subtypes",
        "type": "Information Retrieval",
        "subtype": "Data Aggregation, Grouping and Classification",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "yes, IDH1-TP53: average age 32.3, IDH1-TP53: average age 50.6, TP53-PTEN: average age 68.0, PTEN-TP53: average age 84.0",
        "score": 0
    },
    {
        "question": "How do chromatin modifiers (ATRX, SMARCA4, BCOR) interplay with metabolic alterations (IDH1)? Express as 'ChromatinModifierX: [frequent co-occurance (include %) / rare co-occurance]' for each chromatin modifier.",
        "ground_truth": "ATRX:frequent co-occurance (87.1%), SMARCA4 rare co-occurance, BCOR rare co-occurance.",
        "derivation": "Analysis of chromatin modifier co-occurrence patterns and associations",
        "type": "Information Retrieval",
        "subtype": "Pattern and Trend Recognition",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "ATRX: [frequent co-occurance (86.64%)]\nSMARCA4: [frequent co-occurance (74.07%)]\nBCOR: [frequent co-occurance (48.28%)]",
        "score": 0
    },
    {
        "question": "Calculate distribution of molecular subtypes. Express as 'SUBTYPE: XX.X%, mean age YY.Y years' for each subtype.",
        "ground_truth": "IDH-triple: 20.4%, mean age 38.5 years; IDH-only: 19.8%, mean age 45.8 years; RTK/PI3K: 24.8%, mean age 60.3 years; Other: 35.0%, mean age 54.4 years",
        "derivation": "Integration of molecular subtypes with clinical characteristics",
        "type": "Information Retrieval",
        "subtype": "Data Aggregation, Grouping and Classification",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "IDHwt: 51.8%, mean age 59.5 years; IDHmut_codel: 20.4%, mean age 38.5 years; IDHmut_non-codel: 17.8%, mean age 46.4 years; IDHmut_other: 10.0%, mean age 39.8 years",
        "score": 0
    },
    {
        "question": "Calculate mutation frequencies by age group. Express as 'Age <45: IDH XX.X%, Age >60: RTK/PI3K YY.Y%'.",
        "ground_truth": "Age <45: IDH 83.3%, Age >60: RTK/PI3K 47.2%",
        "derivation": "Analysis of age-stratified molecular patterns and risk factors",
        "type": "Information Retrieval",
        "subtype": "Pattern and Trend Recognition",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "Age <45: IDH 87.9%, Age >60: RTK/PI3K 64.1%",
        "score": 0
    },
    {
        "question": "Calculate mean mutation burden by molecular subtype. Express as 'SUBTYPE: XX.X mutations (mean)'.",
        "ground_truth": "IDH-triple: 3.2 mutations (mean), RTK/PI3K: 1.8 mutations (mean)",
        "derivation": "Integration of mutation burden, pathway analysis, and clinical correlations",
        "type": "Information Retrieval",
        "subtype": "Data Aggregation, Grouping and Classification",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "0: 1.8 mutations (mean)\n1: 1.8 mutations (mean)",
        "score": 0
    },
    {
        "question": "Characterize molecular subtypes by age and prognosis. Express as 'SUBTYPE: onset age XX-YY years, PROGNOSIS' for each subtype.",
        "ground_truth": "IDH-triple: onset age 30-45 years, good prognosis; RTK/PI3K: onset age 55-70 years, poor prognosis",
        "derivation": "Analysis of subtype-specific characteristics and outcomes",
        "type": "Information Retrieval",
        "subtype": "Summary and Reporting",
        "difficulty": "hard",
        "table_path": "./datasets/research/Glioma.csv",
        "result": "The molecular subtypes are characterized as follows:\n\n* IDH1=1, TP53=0, ATRX=0, PTEN=0, EGFR=0, CIC=0, MUC16=0, PIK3CA=1, NF1=0, PIK3R1=0, FUBP1=1, RB1=0, NOTCH1=0, BCOR=0, CSMD3=0, SMARCA4=0, GRIN2A=0, IDH2=0, FAT4=0, PDGFRA=0: onset age 51.3-51.3 years, Grade 0.0\n* IDH1=1, TP53=0, ATRX=0, PTEN=0, EGFR=0, CIC=1, MUC16=0, PIK3CA=0, NF1=0, PIK3R1=0, FUBP1=0, RB1=0, NOTCH1=0, BCOR=0, CSMD3=0, SMARCA4=0, GRIN2A=0, IDH2=0, FAT4=0, PDGFRA=0: onset age 38.7-38.7 years, Grade 0.0\n* IDH1=1, TP53=1, ATRX=1, PTEN=0, EGFR=0, CIC=0, MUC16=0, PIK3CA=0, NF1=0, PIK3R1=0, FUBP1=0, RB1=0, NOTCH1=0, BCOR=0, CSMD3=0, SMARCA4=0, GRIN2A=0, IDH2=0, FAT4=0, PDGFRA=0: onset age 31.5-35.2 years, Grade 0.0\n* IDH1=1, TP53=1, ATRX=1, PTEN=0, EGFR=0, CIC=0, MUC16=1, PIK3CA=0, NF1=0, PIK3R1=1, FUBP1=0, RB1=0, NOTCH1=0, BCOR=0, CSMD3=0, SMARCA4=0, GRIN2A=0, IDH2=0, FAT4=1, PDGFRA=0: onset age 32.8-32.8 years, Grade 0.0",
        "score": 0
    }
]